In one paragraphArticle in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Jing Guan *State Key Laboratory of Respiratory Disease, Department of respiratory, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
Huiqi Qu *Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.ORCID 0000-0001-9317-4488 Lin Yu *Department of Laboratory, The Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University, KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, China.
Weilong LiState Key Laboratory of Respiratory Disease, Department of respiratory, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
Garnet EisterCenter for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Hakon HakonarsonCenter for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.ORCID 0000-0003-2814-7461 Shaoqiang LiState Key Laboratory of Respiratory Disease, Department of respiratory, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.ORCID 0000-0001-9663-5358 Funding
Guangdong Special Support Program Project 2024National Key Research and Development Program of China 2021YFC2301101National Natural Science Foundation of China 82100118Science and Technology Projects in Guangzhou 2023A03J0333
6 · The paper itselfAbstract
IMPORTANCE: This study reveals the emergence of ST697, a novel, highly drug-resistant, and virulent clone of
Indexed as
Acinetobacter baumanniiAcinetobacter InfectionsAnti-Bacterial AgentsCross InfectionDrug Resistance, Multiple, BacterialAnimalsFemaleHumansMiceMicrobial Sensitivity TestsMolecular EpidemiologyVirulenceWhole Genome SequencingAnti-Bacterial AgentsAcinetobacter baumanniiantibiotic combination therapycombined drug susceptibility testmulti-drug resistanceST697
Identifiers
PMID41989189
PMCPMC13227986
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390